Diagnosed With Bladder Cancer After Actos? Call the Drug Litigation Attorneys at Eberstein & Witherite – Marketwatch

February 2, 2012 Posted By: Leave a comment
DALLAS, Feb. 2, 2012 /PRNewswire via COMTEX/ -- Originally prescribed by physicians across America for the treatment of type 2 diabetes, the prescription drug Actos (pioglitazone) was pulled from the market in June 2011 when the US Food and Drug ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>